UNSPSC 51451907: Niclosamide

This classification denotes an antihelminthic agent with the molecular formula C13H8Cl2N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8KK8CQ2K8G, chemically known as 2,5-dichloro-4-nitrosalicylanilide but generally known as niclosamide, which bears US NIH Compound Identifier 4477. European Medicines Agency schedules Niclosamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09230MIG.

UNSPSC 51451907 Niclosamide is a Commodity code that state and local governments are using to tag pharmaceutical and medical supply procurements, though recent solicitations under this code show minimal alignment with the code's nominal scope. The recent opportunities posted against this code are actually soliciting naloxone and drug deactivation systems (Seminole County, Florida), medical and first aid supplies for fire rescue operations (City of Tampa), generic multi-source pharmaceuticals and OTC products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance), and market intelligence on direct-to-manufacturer prescription programs (Texas Health and Human Services Commission). The issuing bodies span county health departments, city fire departments, state agencies administering pharmacy benefit programs, and regional cooperative purchasing vehicles, indicating that the code is being applied broadly across health and human services procurement rather than to a single product category.

Geographic activity is concentrated in the Southeast and Midwest, with recent opportunities from Florida, Texas, and Minnesota, though the MMCAP cooperative purchasing vehicle serves multiple states including Oregon. The most recent representative opportunity is Seminole County, Florida's IFB 60459723LAS (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries. The City of Tampa issued an invitation to bid (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies totaling an estimated $700,000, with a 5 percent bid discount set-aside for certified Small Local Business Enterprises. The Minnesota cooperative purchasing vehicle issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers effective July 1, 2026. The Texas HHS Commission posted an RFI (HHS0017013, due April 3, 2026) exploring vendor capabilities for direct-to-manufacturer prescription programs. The code's application appears misaligned with its nominal scope, suggesting that state and local procurement offices are tagging broader pharmaceutical and medical supply activity under this classification.